Event Information:
Date
November 15th to 19th, 2024
Location
San Diego, California, USA
Related Models
TransCure BioServices at The Liver Meeting 2024 – AASLD
We are excited to announce that Ha-Yeon Kim-Penard, PhD, Business Developer, and Dan Georgess, PhD, Chief Scientific Officer, will be attending The Liver Meeting 2024, organized by the American Association for the Study of Liver Diseases (AASLD), from November 15-19, 2024 in San Diego, USA.
This premier event gathers leading experts in hepatology to explore advancements in liver research and treatments. At TransCure BioServices, we offer specialized humanized mouse models, including the humanized liver mouse model (hu-liver), designed to advance preclinical research in liver diseasessuch as hepatitis, MASH, fibrosis, and more.
If you are attending the event, don’t miss the opportunity to meet with Ha-Yeon and Dan to discuss how our models can support your liver research and accelerate your drug development efforts.
For more information, visit: https://www.aasld.org/the-liver-meeting
Attending in person for TransCure bioServices:
Ha-Yeon Kim-Penard, PhD, Business Development
Ha-Yeon Kim-Penard holds a PhD in Cell and Molecular Biology from the University of Paris, in France. She worked at the Curie Institute (Orsay, France) in the field of cancer biology in cutaneous melanoma, before joining the TransCure bioServices Team as Project Leader in 2020. She has led many in vivo preclinical projects encompassing immuno-oncology, infectious diseases, inflammatory diseases in humanized Immune System and humanized liver mouse models.
Attending in person for TransCure bioServices:
Dan Georgess, PhD, Chief Scientific Officer
Dan is an innovative scientist with extensive international experience in team leadership, research strategy, and interdisciplinary collaboration. He is dedicated to promoting cross-functional efforts to address complex challenges in therapeutics development. Prior to joining TransCure bioServices, Dan was a Marie Curie Ph.D. fellow at ENS de Lyon (France), Suzan G. Komen postdoctoral fellow at the Johns Hopkins School of Medicine (USA), and assistant professor and leader of the Cancer Invasion and Metastasis Cluster at the Lebanese American University (Lebanon). In these roles, he developed cutting-edge in vivo and ex vivo approaches for hematopoiesis, autoimmunity, and cancer research, and co-authored 15 peer-reviewed publications. Since joining TransCure bioServices in 2022, initially as Project Leader then transitioning to Director of the Alliance Management Team and now CSO, Dan’s consistent focus has been to drive successful preclinical development of cell therapies and biologics for TransCure’s clients.